ACTIVE

TERUMO EUROPE

Export PDF

Financial year 2026 · Closed on 31/03/2026

Net result12,1 M €+149,0 %over 1 year

Revenue799,2 M €+5,0 %over 1 year

Equity590,9 M €+28,8 %over 1 year

Workforce721,3 ETP-6,9 %over 1 year

Identity

Source · BCE/KBO

TERUMO EUROPE is a Public limited company incorporated in 1971. Its main activity is: Manufacture of medical and dental instruments and supplies. Its registered office is in Leuven. It employs on average 721,3 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0408.270.327
Incorporation: 05/05/1971
Legal form: Public limited company
Registered office: Interleuvenlaan 40
3001 Leuven · FlandreSee on map
Contributed capital: 415 600 059,00 €
Latest accounts: 31/03/2026
Average workforce: 721,3 ETP

Activities (NACE)

32500Manufacture of medical and dental instruments and supplies· main 32500Manufacture of medical and dental instruments and supplies 33102Repair of fabricated metal products, machinery and equipment 46460Wholesale of pharmaceutical goods 46460Wholesale of pharmaceutical goods 51460Air transport+2

Joint committees (2)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHigh revenue

Financials

Source · NBB, 37 filings

Trend over 18 financial years

	2026		2025		2024		2023		2022
Income statement
Revenue	799,2 M €	+5.0%	761,1 M €	+6.0%	718,3 M €	+8.0%	664,9 M €	+5.6%	630 M €
EBITDA	38,2 M €	-0.5%	38,4 M €	-42.7%	67,1 M €	+70.3%	39,4 M €	-2.0%	40,2 M €
Operating result	26,6 M €	+52.2%	17,5 M €	-69.5%	57,1 M €	+47.3%	38,8 M €	+19.5%	32,5 M €
Net result	12,1 M €	+149%	-24,7 M €	-155%	45,2 M €	+6.1%	42,6 M €	+10.4%	38,5 M €
Balance sheet
Equity	590,9 M €	+28.8%	458,8 M €	-5.1%	483,4 M €	+0.2%	482,3 M €	+9.7%	439,7 M €
Total assets	979,9 M €	+13.6%	862,4 M €	-0.0%	862,5 M €	+12.3%	767,7 M €	+2.4%	749,6 M €
Cash	9,5 M €	+34.6%	7,1 M €	-29.4%	10 M €	-4.3%	10,5 M €	+86.4%	5,6 M €
Debts	362,3 M €	-3.2%	374,2 M €	+3.9%	360,2 M €	+33.4%	269,9 M €	-5.2%	284,6 M €
Other
Workforce	721,3 ETP	-6.9%	775,1 ETP	+2.9%	753,5 ETP	-0.6%	757,7 ETP	-0.8%	763,8 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 250 M€ and 500 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/03/2026

5 active · 20 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Bhawna Menghnani	Director17/04/2023 → 03/07/2026
Hosokai Takuya	Chairman of the board of directors01/04/2023 → 03/07/2026
Itaru Sakaguchi	Director08/04/2024 → 03/07/2026
Jin Hagimoto	Director08/04/2024 → 03/07/2026
Norimasa Kunimoto	Director08/04/2024 → 03/07/2026Chairman of the board of directors01/07/2018 → 01/04/2023ended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Hikaru Samejima	Director02/07/2022 → 08/04/2024
Naoki Muto	Director02/07/2022 → 08/04/2024

Full financial information

Source · NBB

	2026	2025	2024	2023	2022	2021
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/04/2025	01/04/2024	01/04/2023	01/04/2022	01/04/2021	01/04/2020
Closing of the financial year	31/03/2026	31/03/2025	31/03/2024	31/03/2023	31/03/2022	31/03/2021
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	08/07/2026	07/07/2025	16/07/2024	11/07/2023	26/07/2022	16/07/2021
General meeting	03/07/2026	04/07/2025	05/07/2024	07/07/2023	01/07/2022	02/07/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 37 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/03/2026	03/07/2026	08/07/2026	Dutch	PDF
Consolidated accounts	31/03/2026	03/07/2026	10/07/2026	Dutch	PDF
Full model	31/03/2025	04/07/2025	07/07/2025	Dutch	PDF
Consolidated accounts	31/03/2025	04/07/2025	16/07/2025	Dutch	PDF
Full model	31/03/2024	05/07/2024	16/07/2024	Dutch	PDF
Consolidated accounts	31/03/2024	—	17/07/2024	Dutch	PDF
Full model	31/03/2023	07/07/2023	11/07/2023	Dutch	PDF
Consolidated accounts	31/03/2023	04/07/2023	02/10/2023	Dutch	PDF
Full model	31/03/2022	01/07/2022	26/07/2022	Dutch	PDF
Consolidated accounts	31/03/2022	22/06/2022	26/07/2022	Dutch	PDF
Full model	31/03/2021	02/07/2021	16/07/2021	Dutch	PDF
Consolidated accounts	31/03/2021	22/06/2021	16/07/2021	Dutch	PDF
Full model	31/03/2020	03/07/2020	17/07/2020	Dutch	PDF
Consolidated accounts	31/03/2020	25/06/2020	17/07/2020	Dutch	PDF
Full model	31/03/2019	05/07/2019	15/07/2019	Dutch	PDF
Full model	31/03/2018	06/07/2018	24/07/2018	Dutch	PDF
Full model	31/03/2017	07/07/2017	25/07/2017	Dutch	PDF
Full model	31/03/2016	01/07/2016	05/07/2016	Dutch	PDF
Consolidated accounts	31/03/2016	01/07/2016	05/07/2016	Dutch	PDF
Full model	31/03/2015	03/07/2015	28/07/2015	Dutch	PDF
Consolidated accounts	31/03/2015	03/07/2015	29/07/2015	Dutch	PDF
Full model	31/03/2014	04/07/2014	09/07/2014	Dutch	PDF
Consolidated accounts	31/03/2014	04/07/2014	09/07/2014	Dutch	PDF
Full model	31/03/2013	05/07/2013	08/08/2013	Dutch	PDF
Consolidated accounts	31/03/2013	05/07/2013	08/08/2013	Dutch	PDF
Full model	31/03/2012	06/07/2012	27/07/2012	Dutch	PDF
Consolidated accounts	31/03/2012	06/07/2012	27/07/2012	Dutch	PDF
Full model	31/03/2011	01/07/2011	02/08/2011	Dutch	PDF
Consolidated accounts	31/03/2011	01/07/2011	03/08/2011	Dutch	PDF
Full model	31/03/2010	02/07/2010	23/08/2010	Dutch	PDF
Consolidated accounts	31/03/2010	02/07/2010	23/08/2010	Dutch	PDF
Full model	31/03/2009	03/07/2009	25/08/2009	Dutch	PDF
Consolidated accounts	31/03/2009	03/07/2009	25/08/2009	Dutch	PDF
Full model	31/03/2008	04/07/2008	09/07/2008	Dutch	PDF
Consolidated accounts	31/03/2008	04/07/2008	09/07/2008	Dutch	PDF
Full model	31/03/2007	06/07/2007	13/07/2007	Dutch	PDF
Consolidated accounts	31/03/2007	06/07/2007	13/07/2007	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 M€ and 500 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/03/2026

5 active · 20 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Bhawna Menghnani	Director17/04/2023 → 03/07/2026
Hosokai Takuya	Chairman of the board of directors01/04/2023 → 03/07/2026
Itaru Sakaguchi	Director08/04/2024 → 03/07/2026
Jin Hagimoto	Director08/04/2024 → 03/07/2026
Norimasa Kunimoto	Director08/04/2024 → 03/07/2026Chairman of the board of directors01/07/2018 → 01/04/2023ended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Hikaru Samejima	Director02/07/2022 → 08/04/2024
Naoki Muto	Director02/07/2022 → 08/04/2024

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Other26/08/2026
Oprichting branch Nederland, Handtekeningsbevoegdheid, herbenoeming
PDF
Mandates19/09/2025
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares17/09/2025
KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates16/04/2025
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares16/04/2025
KAPITAAL - AANDELEN
PDF
Mandates09/09/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates10/05/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates10/05/2024
ONTSLAGEN - BENOEMINGEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings18 filings

Mandates

Hosokai Takuya

Itaru Sakaguchi

Jin Hagimoto

Norimasa Kunimoto

Bhawna Menghnani

Hikaru Samejima

Sebastian Vanloot

Naoki Muto

Shoji Hatano

Peter Coenen

Kyo Nishikawa

Benoit De Saeger

and 13 more mandates

19711972197319741975197619771978197919801981198219831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026

TERUMO EUROPE

Interleuvenlaan 40, 3001 Heverlee

Chairman of the board of directors

Director

DirectorChairman of the board of directors

Director

Chairman of the board of directorsDirector

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Interleuvenlaan 40, 3001 HeverleeCurrent	accounts 2022 → 2026	Accounts 2026 · 2026-00267726

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
TERUMO EUROPECurrent	accounts 2009 → 2026	Accounts 2026 · 2026-00267726

Events

2026
Annual accounts 202612,1 M €↑
04/08/2025
augmentation_capital
04/07/2025
reconductionTakuya Hosokai · bestuurder
04/07/2025
reconductionNorimasa Kunimoto · bestuurder
04/07/2025
reconductionItaru Sakaguchi · bestuurder
04/07/2025
reconductionJin Hagimoto · bestuurder
04/07/2025
reconductionBhawna Menghnani · bestuurder
04/07/2025
nominationRaf Cox · commissaris
2025
Annual accounts 2025-24,7 M €↓
01/03/2025
nominationWinnie Prendergast · gevolmachtigde
02/01/2025
nominationChristian Baiotto · General Manager Hospital Care Solutions EMEA (HCS) / gevolmachtigde
02/01/2025
nominationSarah Wijns · bijzonder gevolmachtigde
02/01/2025
nominationAnja Heylen · bijzonder gevolmachtigde
05/07/2024
reconductionTakuya Hosokai · bestuurder
05/07/2024
reconductionNorimasa Kunimoto · bestuurder
05/07/2024
reconductionItaru Sakaguchi · bestuurder
05/07/2024
reconductionJin Hagimoto · bestuurder
05/07/2024
reconductionBhawna Menghnani · bestuurder
08/04/2024
nominationNorimasa KUNIMOTO · bestuurder
08/04/2024
nominationItaru SAKAGUCHI · bestuurder
08/04/2024
nominationJin HAGIMOTO · bestuurder
2024
Annual accounts 202445,2 M €↑
07/07/2023
reconductionTakuya Hosokai · bestuurder
07/07/2023
reconductionBhawna Menghnani · bestuurder
07/07/2023
reconductionHikaru Samejima · bestuurder
07/07/2023
reconductionShoji Hatano · bestuurder
07/07/2023
reconductionNaoki Muto · bestuurder
17/04/2023
nominationBhawna MENGHNANI · bestuurder
01/04/2023
nominationTakuya HOSOKAI · bestuurder
2023
Annual accounts 202342,6 M €↑
02/11/2022
nominationIhsen Merioua · Chief Medical en Clinical Officer EMCD EMEA
2022
Annual accounts 202238,5 M €↑
2021
Annual accounts 202124,4 M €↑
2020
Annual accounts 202017,6 M €↑
2019
Annual accounts 201914,1 M €↓
2018
Annual accounts 201825,8 M €↓
2017
Annual accounts 201739,8 M €↑
2016
Annual accounts 201637,5 M €↑
2015
Annual accounts 20151,7 M €↓
2014
Annual accounts 201425,5 M €↓
2013
Annual accounts 201338,2 M €↑
2012
Annual accounts 201229,4 M €↓
2011
Annual accounts 201131,8 M €↓
2010
Annual accounts 201045,5 M €↑
2009
Annual accounts 200936,5 M €
05/05/1971
IncorporationPublic limited company

TERUMO EUROPE

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events